Taro Pharmaceuticals – Recall of lamotrigine
January 10, 2020 - Taro Pharmaceuticals announced a voluntary, consumer-level recall of lamotrigine tablets because one lot was found to have been cross-contaminated with a small amount of another drug substance, enalapril maleate, used to manufacture another product at the same facility.
Top